Safety and efficacy of Vitamin D(3) supplementation with Imatinib in Chronic Phase- Chronic Myeloid Leukaemia: an Exploratory Randomized Controlled Trial

OBJECTIVES: The study aimed to compare early molecular response (EMR) rates at 3 months of imatinib therapy with and without vitamin D(3) supplementation in patients newly diagnosed with chronic-phase chronic myeloid leukaemia (CML-CP). The secondary objective was to assess the effects of vitamin D(...

Descripción completa

Detalles Bibliográficos
Autores principales: Bandyopadhyay, Arkapal, Palepu, Sarika, Dhamija, Puneet, Nath, Uttam Kumar, Chetia, Rituparna, Bakliwal, Anamika, Vaniyath, Sudeep, Chattopadhyay, Debranjani, Handu, Shailendra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465917/
https://www.ncbi.nlm.nih.gov/pubmed/37643857
http://dx.doi.org/10.1136/bmjopen-2022-066361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465917/
https://www.ncbi.nlm.nih.gov/pubmed/37643857
http://dx.doi.org/10.1136/bmjopen-2022-066361

Ejemplares similares